Захарченко А.В.

Introduction. The alfuzosin and solifenacin combination has previously demonstrated high efficacy and safety in patients with BPH and overactive bladder (OAB), including with severe LUTS, if cases of mechanical type of bladder outlet obstruction (BOO) were excluded. The present study aim was to confirm the efficacy and safety of such combination therapy in patients with severe urinary disorders according to uroflowmetry (UFM).

Introduction. Recently, the first generalized data on the efficacy and safety of alfuzosin (Alfuprost® MR) and solifenacin (Vesigamp) combination therapy (CT) in patients with LUTS/BPH and hyperactive bladder (ОАВ) have been published based on the results of the multicenter observational «AVIATOR» study. This was the first study of alfuzosin and solifenacin combination, in which a set of validated questionnaires was used to assess symptoms.

The results the of the comparative study of biofeedback with test electrostimulation of the pelvic floor muscles as monotherapy and in combinationwith extra-corporeal magnetic stimulation of the pelvic floor muscles with functional infravesical obstruction in women

Introduction. The functional bladder outlet obstruction (fBOO) in women is one of the urgent and dif-ficult tasks of functional urology. As a conservative treatment, pelvic floor muscle training is widely used, including using the method of biofeedback (BFB).

Introduction. the issue of choosing a proper method of treatment and diagnosticsfor chronic abacterial prostatitis/ chronic pelvic pain syndrome (CPPS) is a topic for extensive scientific discussion. Etiology of this condition isinsufficiently studied, and guidelines on itstreatment are controversial. Moreover, patients with CPPS and their partners experience negative impact of pain on sexual and interpersonal relations, sexual activity, satisfaction and quality of life.

Introduction: Psychopathological diseases in urological patients cohort became the object of interest during last years. Insomnia is one of the most frequent. The main complaints are decreased working capacity, mood changes, decreased social adaptation and quality of life

Objective: To evaluate sleep disorders changes in adults with neurogenic detrusor overactivity (NDO) after botulinum toxin type A (BTA) treatment.

Clinical manifestations of neurogenic bladder dysfunction (NBD) have a significant impact on all aspects of life — social, family, professional and sexual. 

Anxiety, depression and other psychological problems occur often as complications of somatic diseases, including the neurogenic dysfunction of the urinary bladder (NDUB), which appears as the urgency, often together with the urgent urinary incontinence (UUI). 

Lower urinary tract dysfunction, related to the neurological diseases/neural damage (neurological infections, spinal disorders, trauma, cerebrovascular problems, etc.) is one of the frequent reasons for the consultation by neurourologist. 

One of the perspective methods of the treatment in patients with neurogenic lower urinary tract dysfunction (NLUTD) is biofeedback therapy combined with electrostimulation of the pelvic floor muscles. The advantages of this treatment are noninvasive nature, treatment in the form of playing, rising the commitment of the children, special facilities to demonstrate the achieved results to the patients, easy change of therapeutic strategies and introduction in the treatment for patients, absence of absolute contraindications.

Currently female micturition disorders problem is one of the most actual and complicated one in urology. One of the most common disorders is stress incontinence, which frequency rates up to 70% in women after 50 years. According to publications every fifth woman in any period of her life suffers from incontinence with negative influence on her quality of life. Biofeedback efficiency study in patients with mild and moderate stress incontinence was conducted in scientific research institute of urology of Moscow.